We attempted to send a notification to your email address but we were unable to verify that you provided a valid email address.
Please visit my profile to update your email address if you wish to receive notifications.
Otherwise, disable notifications and hide this message.
Your session was unable to be renewed and will be expiring in 0 seconds.
Click here to attempt to renew your session.
Sweeten your coffee routine with café-style flavor at home
Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
![[Loading...]](https://media-sixrivers.mynews360.com/images/loading.gif "Loading...")
